For licensed medical professionals and compounding pharmacies only. Not for sale to the general public.  ·  787-822-8197
Licensed clinic purchasing

Wholesale peptide sourcing for longevity clinics.

Longevity practices often evaluate a varied service menu. Each preparation needs its own evidence review and purchasing specification; a “longevity” label does not establish an approved indication, clinical benefit, or eligibility for compounding.

High-end longevity clinic with premium pharmaceutical vials on the counter

Review each preparation on its own merits

Keep clinical evidence, regulatory status, and supplier qualification as separate questions. A promising mechanism or a product’s appearance in another clinic’s menu does not answer any of them. FDA identifies safety concerns for several peptides marketed in this area, including thymosin-alpha-1 and MOTs-C.

Avoid one storage rule for a mixed menu

Record the labeled storage conditions and expiry or beyond-use date for each approved presentation. Do not assume different preparations share refrigeration, light-protection, or handling requirements. Establish receiving and quarantine procedures with the clinical or quality lead using our cold-chain guide.

Control low-volume inventory and expiry

Review slower-moving items individually rather than rolling them into an overall purchasing budget. A volume discount has little value if stock expires before use. Compare minimum order quantities with expected consumption and confirmed usable shelf life; request those details in the quote rather than assuming them.

Make each lot traceable through the practice

Link the approved purchase, shipment records, lot-specific documents, inventory movements, and applicable clinical records within your own secure systems. Our COA guide explains how to review identity and test results without mistaking purity for clinical suitability.

Product information for your sourcing review

Use these catalog references to identify questions, not as confirmation of stock or authorization to purchase for treatment. Product-specific regulatory review takes priority over catalog labels.

Clinic purchasing guides

Compare the supplier checklist resource and our testing documentation guidance when preparing your questions.

Questions from longevity clinics

No. A marketing category is not an approved indication or evidence of benefit. Evaluate each proposed product with qualified clinical and regulatory reviewers.

Forecast low-volume items separately, rotate stock by the earliest usable expiry, and compare order minimums with realistic consumption and storage capacity.

No. Identity, strength, relevant impurities, sterility, endotoxin controls, labeling, source, and regulatory suitability are separate considerations. A single purity percentage cannot establish all of them.

Regulatory sources and purchasing limits

Compounded drugs are not FDA-approved. Facility registration does not establish approval or eligibility for every preparation. Verify the exact product, source, applicable federal requirements, and state rules before ordering. This is procurement education, not medical or legal advice.

Compare requirements across all clinic specialties.

Tell us what your clinic needs.

Send your facility details, destination state, exact product requirements, and expected volume. Availability and order terms require review.

Compare exact product references

Use these pages to prepare specific identity and documentation questions. Inclusion here does not establish clinical suitability, stock or permission to purchase for treatment.

Call Apply for Wholesale